Journal Mobile Options
Table of Contents
Vol. 37, No. 3, 2005
Issue release date: May–June 2005
Ophthalmic Res 2005;37:136–141
(DOI:10.1159/000085533)

Melanin Aggregation and Polymerization: Possible Implications in Age-Related Macular Degeneration

Sarangarajan R. · Apte S.P.
Department of Phamaceutical Sciences, Massachusetts College of Pharmacy and Health Sciences, Worcester, Mass., USA

Individual Users: Register with Karger Login Information

Please create your User ID & Password





Contact Information











I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Abstract

The state of aggregation of the polymer melanin may determine its propensity to act either as an antioxidant or as a pro-oxidant. Age-related alterations in its state of aggregation are suggested to alter the degree of polymerization so as to confer increased pro-oxidant propensity to the melanin polymer. Degradative processes in/of melanosomes and lysosomes in the retinal pigment epithelium (RPE) appear to be intimately connected so that they may involve exchange of contents between these two organelles. An increased pro-oxidant environment inside lysosomes has been associated with preventing the digestion of cellular components including photoreceptor outer rod segments partly by altering function of lysosomal hydrolases. It is speculated that age-related accumulation of low-molecular-weight phototoxic pro-oxidant melanin oligomers within lysosomes in the RPE may be partly responsible for decreasing the digestive rate of incorporated cellular components (including photoreceptor outer rod segments) which may lead to lipofuscin formation. More work is required to definitively refute or support such a hypothesis.



Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

References

  1. Stone EM, Sheffield VC, Hageman GS: Molecular genetics of age-related macular degeneration. Hum Mol Genet 2001;10:2285–2292.
  2. Chopdar A, Chakravarthy U, Verma D: Age-related macular degeneration. BMJ 2003;326:485–488.
  3. Sarna T, Burke JM, Korytowski W, et al: Loss of melanin from human RPE with aging: Possible role of melanin photooxidation. Exp Eye Res 2003;76:89–98.
  4. Sarna T: Properties and function of the ocular melanin – A photobiological view. J Photochem Photobiol B Biol 1992;12:215–258.
  5. Boulton M:The role of melanin in the RPE; in Marmor M, Wolfensberger T (eds): The Retinal Pigment Epithelium. Oxford, Oxford University Press, 1998, pp 68–85.
  6. Stjernschantz J, et al: Increased pigmentation of iridial melanocytes in primates induced by a prostaglandin analogue. Exp Eye Res 1999;68:431–436.
  7. Levin LA, Dutkiewicz R, Albert DM: Effects of latanoprost on tyrosinase activity and mitotic index of cultured melanoma lines. Exp Eye Res 2000;70:563–569.
  8. Dayhaw-Barker P: Retinal pigment epithelium melanin and ocular toxicity. Int J Toxicol 2002;21:451–454.
  9. Kayatz P, Thumann G, Luther TT, et al: Oxidation causes melanin fluorescence. Invest Ophthalmol Vis Sci 2001;42:241–246.
  10. Borovansky J, Elleder M: Melanosome degradation: Fact or fiction. Pigment Cell Res 2003;16:280–286.
  11. Hegedus ZL: The probable involvement of soluble and deposited melanins, their intermediates and the reactive oxygen side-products in human diseases and aging. Toxicology 2000;145:85–101.
  12. Rozanowska M, Korytowski W, Rozanowski B, et al: Photoreactivity of aged human RPE melanosomes: A comparison with lipofuscin. Invest Ophthalmol Vis Sci 2002;43:2088–2096.
  13. Nofsinger JB, Liu Y, Simon JD: Aggregation of eumelanin mitigates photogeneration of reactive oxygen species. Free Radic Biol Med 2002;32:720–730.
  14. Simon JD, Liu Y, Nofsinger JB: Assembly and aerobic photoreactivity of melanin. Spectrum 2002;15:1–6.
  15. Littrell KC, Gallas JM, Zajac GW, et al: Structural studies of bleached melanin by synchrotron small angle X-ray scattering. Photochem Photobiol 2003;77:115–120.
  16. Pascutti PG, Ito AS: EPR study of melanin-protein interaction – Photoinduced free radicals and progressive microwave power saturation. J Photochem Photobiol B 1992;16:257–266.
  17. Kollias N, Baqer AH: Absorption mechanisms of human melanin in the visible, 400–720 nm. J Invest Dermatol 1987;89:384–388.
  18. Orlow SJ: Melanosomes are specialized members of the lysosomal lineage of organelles. J Invest Dermatol 1995;105:3–7.
  19. Diment S, Eidelman M, Rodriguez GM, et al: Lysosomal hydrolases are present in melanosomes and are elevated in melanizing cells. J Biol Chem 1995;270:4213–4215.
  20. Schraermeyer U, Peters S, Thumann G, et al: Melanin granules of retinal pigment epithelium are connected with the lysosomal degradation pathway. Exp Eye Res 1999;68:237–245.
  21. Feeney L: Lipofuscin and melanin of human retinal pigment epithelium: Fluorescence, enzyme cytochemical, and ultrastructural studies. Invest Ophthalmol Vis Sci 1978;17:583–600.
  22. Clancy CMR, Nofsinger JB, Hanks RK, et al: Hierarchical self-assembling of eumelanin. J Phys Chem B 2000;104:7871–7873.
  23. Zajac GW, Gallas JM, Cheng J, et al: The fundamental unit of melanin: A verification by tunneling microscopy of X-ray scattering results. Biochim Biophys Acta 1994;1199:271–278.
  24. Gallas JM, Littrell KC, Seifert S, et al: Solution structure of copper ion-induced molecular aggregates of tyrosine melanin. Biophys J 1999;77:1135–1142.
  25. Sharma AK, Kumar S, Sharma V, et al: Lactoferrin-melanin interaction and its possible implications in melanin polymerization: Crystal structure of the complex formed between mare lactoferrin and melanin monomers at 2.7 A resolution. Proteins 2001;45:229–236.
  26. Kono R, Jimbow K, Takahashi H, et al: Ultrasonic measurement of melanosomes for characterization of their physicochemical structure in B16 and Harding-Passey melanomas. Cancer Res 1984;44:4337–4341.
  27. Sharma S, Wagh S, Govindarajan R: Melanosomal proteins – Role in melanin polymerization. Pigment Cell Res 2002;15:127–133.
  28. Donatien PD, Orlow SJ: Interaction of melanosomal proteins with melanin. Eur J Biochem 1995;232:159–164.
  29. Wagh S, Ramaiah A, Subramanian R, et al: Melanosomal proteins promote melanin polymerization. Pigment Cell Res 2000;13:442–448.
  30. Borovansky J, Hach P, Duchon J: Melanosome: An unusually resistant subcellular particle. Cell Biol Int Rep 1977;1:549–554.
  31. Riley PA: Melanin. Int J Biochem Cell Biol 1997;29:1235–129.
  32. Metodiewa D, Jaiswal AK, Cenas N, et al: Quercetin may act as a cytotoxic prooxidant after its metabolic activation to semiquinone and quinoidal products. Free Radic Biol Med 1999;26:107–116.
  33. Nohl H, Gille L, Kozlov AV, et al: Antioxidant-derived prooxidant formation from ubiquinol. Free Radic Biol Med 1998;25:666–675.
  34. Mani I, Sharma V, Tamboli I, et al: Interaction of melanin with proteins – The importance of an acidic intramelanosomal pH. Pigment Cell Res 2001;14:170–179.
  35. Kim IT, Choi JB: Melanosomes of retinal pigment epithelium – Distribution, shape, and acid phosphatase activity. Korean J Ophthalmol 1998;12:85–91.
  36. Takeuchi YK, Takeuchi IK, Kajishima T: Inhibition of melanosome transformation in embryonic chick pigment retina cultured in vitro. J Exp Zool 1975;192:391–400.
  37. Garcia RI, Flynn EA., Szabo G: Autophagocytosis of melanosomes in cultured embryonic retinal pigment cells. Experientia 1983;39:391–392.
  38. Feeney L: Lipofuscin and melanin of human retinal pigment epithelium: Fluorescence, enzyme cytochemical, and ultrastructural studies. Invest Ophthalmol Vis Sci 1978;17:583–589.
  39. Endo H, Hu F: Pigment cell development in rhesus monkey eyes: An electron microscopic and histochemical study. Dev Biol 1973;32:69–81.
  40. Kato T, Ito S, Fujita K, et al: Tyrosine catalyzed binding of 3,4-dihydroxyphenylalanine with proteins through the sulfhydryl group. Biochim Biophys Acta 1986;881:415–421.
  41. Urabe K, Aroca P, Tsukamoto K, et al: The inherent cytotoxicity of melanin precursors: A revision. Biochim Biophys Acta 1994;1221:272–278.
  42. Terman A, Brunk UT: Lipofuscin: Mechanisms of formation and increase with age. APMIS 1998;106:265–276.
  43. Harman D: Aging: A theory based on free radical and radiation chemistry. J Gerontol 1956;211:298–300.

    External Resources

  44. Kikugawa K, Kato T, Beppu M, et al: Fluorescent and cross-linked proteins formed by free radical and aldehyde species generated during lipid oxidation. Adv Exp Med. Biol 1989;266:345–357.
  45. Haralampus-Grynaviski NM, Lamb LE, Clancy CMR, et al: Spectroscopic and morphological studies of human retinal lipofuscin granules. Proc Natl Acad Sci USA 2003;100:3179–3184.
  46. Pawlak A, Rozanowska M, Zareba M, et al: Action spectra for the photoconsumption of oxygen by human ocular lipofuscin and lipofuscin extracts. Arch Biochem Biophys 2002;403:59–62.
  47. Geng L, Wihlmark U, Algvere PV: Lipofuscin accumulation in iris pigment epithelial cells exposed to photoreceptor outer segments. Exp Eye Res 1999;69:539–546.
  48. Kennedy CJ, Rakoczy PE, Robertson TA, et al: Kinetic studies on phagocytosis and lysosomal digestion of rod outer segments by human retinal pigment epithelial cells in vitro. Exp Cell Res 1994;210:209–214.
  49. Ivy GO, Roopsingh R, Kanai S, et al: Leupeptin causes an accumulation of lipofuscin-like substances and other signs of aging in kidneys of young rats: Further evidence for the protease inhibitor model of aging. Ann NY Acad Sci 1996;786:12–23.
  50. Wihlmark U, Wrigstad A, Roberg K, et al: Formation of lipofuscin in cultured retinal pigment epithelial cells exposed to pre-oxidized photoreceptor outer segments. APMIS 1996;104:272–279.
  51. Ozeki H, Wakamatsu K, Ito S, et al: Chemical characterization of eumelanins with special emphasis on 5,6-dihydroxyindole-2-carboxylic acid content and molecular size. Anal Biochem 1997;248:149–157.
  52. Blarzino C, Mosca L, Foppoli C, et al: Lipoxygenase/H2O2-catalyzed oxidation of dihydroxyindoles: Synthesis of melanin pigments and study of their antioxidant properties. Free Radic Biol Med 1999;26:446–453.
  53. Aroca P, Solano F, Salinas C, et al: Regulation of the final phase of mammalian melanogenesis: The role of dopachrome tautomerase and the ratio between 5,6-dihydroxyindole-2-carboxylic acid and 5,6-dihydroxyindole. Eur J Biochem 1992;208:155–163.
  54. Fuller BB, Spaulding DT, Smith DR: Regulation of the catalytic activity of preexisting tyrosinase in black and Caucasian human melanocyte cell cultures. Exp Cell Res 2001;262:197–208.
  55. Ancans J, Tobin DJ, Hoogduijn MJ, et al: Melanosomal pH controls the rate of melanogenesis, eumelanin/phaeomelanin ratio and melanosome maturation in melanocytes and melanoma cells. Exp Cell Res 2001;268:26–35.
  56. Ancans J, Thody AJ: Activation of melanogenesis by vacuolar type H+-ATPase inhibitors in amelanotic, tyrosinase positive human and mouse melanoma cells. FEBS Lett 2000;478:57–60.
  57. Rodrigues-Lopez JN, Tudela J, Varon R, et al: Kinetic study on the effect of pH on the melanin biosynthesis pathway. Biochim Biophys Acta 1991;1076:379–386.
  58. Bhatnagar V, Anjaiah S, Puri N, et al: pH of melanosomes of B 16 murine melanoma is acidic: Its physiological importance in the regulation of melanin biosynthesis. Arch Biochem Biophys 1993;307:183–192.
  59. Mishima Y: Molecular and biological control of melanogenesis through tyrosinase genes and intrinsic and extrinsic regulatory factors. Pigment Cell Res 1994;7:376–387.
  60. Bodnar AG, Ouellette M, Frolkis M, et al: Extension of life-span by introduction of telomerase into normal human cells. Science 1998;279:349–352.
  61. Brunk UT, Terman A: Lipofuscin: Mechanisms of age-related accumulation and influence on cell function. Free Radic Biol Med 2002;33:611–619.
  62. Sarangarajan R, Apte SP: Ocular melanogenesis: The role of antioxidants. Ophthalmic Res 2004;36:303–311.


Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50